Literature DB >> 1833663

The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas.

M R Quigley1, J C Maroon.   

Abstract

Current neurosurgical opinion favors the radical surgical removal of supratentorial gliomas, when feasible, in the belief that this optimizes patient survival. Although bolstered by the results of some early investigators, the efficacy of this approach remains debatable. Therefore, we undertook a review of the English language literature of the past 30 years for a series of surgically treated malignant gliomas. Twenty reports comprising 5691 patients were identified. Only 4 found the extent of the surgical resection related to survival. In 2 of these, it followed age, histological findings, and performance status in importance. The 2 other studies did not rank the prognostic variables at all. On closer inspection, however, there does appear to be a subgroup of young patients with favorable histological findings and good performance status for whom surgery is beneficial. Future reporting of surgical results of patients with gliomas will require stratification by the known prognostic variables of age, histological findings, and performance status to characterize better this subgroup for whom surgery is beneficial.

Entities:  

Mesh:

Year:  1991        PMID: 1833663     DOI: 10.1097/00006123-199109000-00008

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  25 in total

Review 1.  Extent of resection as a prognostic variable in the treatment of gliomas.

Authors:  K R Hess
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

2.  [Palliative therapy in glioblastoma multiforme: a multimodal concept].

Authors:  Viktoria Faber; Ralf Thödtmann; Christine Marosi
Journal:  Wien Med Wochenschr       Date:  2006-05

3.  Effects of vitamin D and retinoic acid on human glioblastoma cell lines.

Authors:  L Magrassi; G Butti; S Pezzotta; L Infuso; G Milanesi
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 4.  Complications and expected outcome of glioma surgery.

Authors:  K P Vives; J M Piepmeier
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

5.  Spin-echo echo-planar perfusion prior to chemoradiation is a strong independent predictor of progression-free and overall survival in newly diagnosed glioblastoma.

Authors:  Ayca Akgoz; Rifaquat Rahman; Hui You; Jinrong Qu; Alhafidz Hamdan; Ravi T Seethamraju; Patrick Y Wen; Geoffrey S Young
Journal:  J Neurooncol       Date:  2014-05-04       Impact factor: 4.130

6.  Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma.

Authors:  Graziella Filippini; Chiara Falcone; Amerigo Boiardi; Giovanni Broggi; Maria G Bruzzone; Dario Caldiroli; Rita Farina; Mariangela Farinotti; Laura Fariselli; Gaetano Finocchiaro; Sergio Giombini; Bianca Pollo; Mario Savoiardo; Carlo L Solero; Maria G Valsecchi
Journal:  Neuro Oncol       Date:  2007-11-09       Impact factor: 12.300

7.  Real-time multi-modality imaging of glioblastoma tumor resection and recurrence.

Authors:  Shawn Hingtgen; Jose-Luiz Figueiredo; Christian Farrar; Matthias Duebgen; Jordi Martinez-Quintanilla; Deepak Bhere; Khalid Shah
Journal:  J Neurooncol       Date:  2012-12-16       Impact factor: 4.130

8.  Clinical course of high-grade glioma patients with a "biopsy-only" surgical approach: a need for individualised treatment.

Authors:  C Balaña; J Capellades; P Teixidor; I Roussos; R Ballester; M Cuello; A Arellano; R Florensa; R Rosell
Journal:  Clin Transl Oncol       Date:  2007-12       Impact factor: 3.405

9.  Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome.

Authors:  Kevin R Kozak; Anand Mahadevan; John S Moody
Journal:  Neuro Oncol       Date:  2008-09-09       Impact factor: 12.300

10.  Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.

Authors:  Branislav Jeremic; Biljana Milicic; Danica Grujicic; Aleksandar Dagovic; Jasna Aleksandrovic
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-15       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.